RT Journal Article
SR Electronic
T1 The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen,Hubei,China
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.07.20031393
DO 10.1101/2020.03.07.20031393
A1 Qijun Gao
A1 Yingfu Hu
A1 Zhiguo Dai
A1 Feng Xiao
A1 Jing Wang
A1 Jing Wu
YR 2020
UL http://medrxiv.org/content/early/2020/03/10/2020.03.07.20031393.abstract
AB Background Some articles have reported the epidemiological and clinical characteristics of coronavirus disease (COVID-19) in Wuhan, but other cities have rarely been reported. This study explored the epidemiology of COVID-19 in Jingmen.Methods All confirmed cases of COVID-19 in the First People’s Hospital of Jingmen are included from January 12 to February 14,2020. Cases were analyzed for epidemiological data and were confirmed by real-time PCR.Findings Of the 213 cases (108 men and 105 women), 88 (41%) had exposure to Wuhan. The median age was 48 years (range,2-88 years;IQR,35-58.5). Thirty-three severe patients with a median age of 66 years(range,33-82 years,IQR, 57-76) were treated in intensive care units; out of these patients, 66.7 %(22) were men and 19 (57.5%) had chronic diseases, including hypertension, diabetes, heart failure, stroke, and renal insufficiency. Under the controlled measures, the number of new patients gradually decreased and nearly disappeared after 20 days.Interpretation All people are susceptible to the COVID-19, but older males and those with comorbid conditions are more likely to have severe symptoms. Even though COVID-19 is highly contagious, control measures have proven to be very effective.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialRetrospective studyFunding Statementno fundAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are from the first hospital of Jingmen,if more information are needed, contact the author.